BONUS ZERTIFIKAT - SANOFI Share Price

Certificat

DE000VM8RW84

Market Closed - Boerse Frankfurt Warrants 19:02:01 24/05/2024 BST
118.4 EUR -0.18% Intraday chart for BONUS ZERTIFIKAT - SANOFI
Current month+0.31%
1 month+1.80%
Date Price Change
24/05/24 118.4 -0.18%
23/05/24 118.6 -0.29%
22/05/24 118.9 +0.25%
21/05/24 118.6 +0.32%
20/05/24 118.2 +0.08%

Real-time Boerse Frankfurt Warrants

Last update May 24, 2024 at 07:02 pm

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer Vontobel Vontobel
WKN VM8RW8
ISINDE000VM8RW84
Date issued 25/01/2024
Strike 120
Maturity 20/09/2024 (117 Days)
Parity 1 : 1
Emission price 115.1
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 118.9
Lowest since issue 113.6
Spread 0.49
Spread %0.41%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
89.52 EUR
Average target price
108.2 EUR
Spread / Average Target
+20.86%
Consensus